The Medtechy Week in Review: March 1, 2019
Posted on March 01, 2019 by Medtech[y] Staff
Welcome to The Medtechy Weekly Review where we curate all of the best news and forum content in one place.
Check back to our homepage to get the latest news and insight for the medical technology industry, including medical device, biotech and digital health.
Top Articles of the Week
According to Cardiologist Dr. Phil Massey of Pacific Medical Centers in Seattle, a patient with a history of Atrial Fibrillation (AFib) was alerted to an abnormal heart rhythm from his Apple Watch Series 4.
General Electric's plans for an IPO have apparently been scratched as reports indicate the company is selling its biopharma business Danaher for $21.4 billion.
Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix, a novel cryoablation technology for the treatment of chronic rhinitis.
In early trading, TransEnterix is down almost 10%, dipping below $3 after announcing an uninspiring Q4 earnings report.
Medtronic ($MDT) today announced the FDA approval of its Resolute Drug-Eluting Stent platform (including the Resolute Onyx and Resolute Integrity DES.
Today, the FDA issued a safety communication to patients and health care providers urging caution when using robotically-assisted surgical devices for mastectomy and other cancer related surgeries.
Most Active Forum Threads
- Johnson & Johnson Company Forum: Jabil Strategic Collaboration
- AbbVie Company Forum: AbbVie's Rick Gonzalez and other pharma executives prepping for congressional grilling
- Depuy Synthes Company Forum: Depuy Synthes Jabil
- Nuvectra Company Forum: New CEO Fred Parks
- Medtronic Company Forum: Surprise Furlough at Medtronic
Medical Sales Rep- Medical Simulation
HealthMed Recruiting - Rochester, NY
Company vehicle and Superior full benefits package!